Nanotechnology Now

Our NanoNews Digest Sponsors



Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Nanoink appoints Dean Hart executive vice president commercial operations

Abstract:
NanoInk, Inc. announced today the appointment of Dean Hart, as its executive vice president of commercial operations.

Nanoink appoints Dean Hart executive vice president commercial operations

SKOKIE, IL | Posted on February 19th, 2008

"We are extremely pleased that Dean has joined the NanoInk team," said Jim Hussey, CEO of NanoInk. "His track record of success and commercial experience will be important to our plans for both Brand Protection and Dip Pen Nanolithography businesses."

Mr. Hart joins NanoInk from Vision Point of Sale, Inc., a leading point-of-sale equipment and services company located in Glenview, Ill., where he served as vice president of sales and marketing during the past two years.

Prior to joining Vision Point of Sale, Mr. Hart served as senior vice president of sales at Takeda Pharmaceuticals North America, Inc., a Deerfield, Ill.-based U.S. subsidiary of Takeda Pharmaceutical Company Limited, Japan's largest pharmaceutical company. At Takeda, he was instrumental in the success of Takeda's flagship diabetes product and market leader, ACTOS®, and led the growth of Takeda's sales force to support the launch of two new products in the diabetes and sleep market.

Previously, Mr. Hart served as president of Sequest Technologies, where he successfully established a market presence for the Oakbrook, Ill. software company in the health care technology field.

Mr. Hart began his career in sales, marketing and sales management at Bristol-Myers Squibb where he held positions of increased responsibility up to and including his appointment to associate director regional operations in 1994. He became the national sales director for the U.S. subsidiary of the Japanese pharmaceutical company Eisai, Inc. in 1996. At Eisai, Mr. Hart built the sales organization and successfully launched Eisai's first product in the U.S. pharmaceutical marketplace, Aricept®, the most prescribed drug in the world for the treatment of Alzheimer's.

Mr. Hart holds a B.S. in Business Management from Indiana University and a Masters of Business Administration from the Kellogg School of Management at Northwestern University.

####

About NanoInk, Inc.
NanoInk, Inc. is an emerging growth technology company specializing in nanometer-scale manufacturing and applications development for the lifescience and semiconductor industries. With DPN, a patented and proprietary nanofabrication technology that allows for unmatched flexibility and accuracy, and also its high-resolution Nanoencryption technology, NanoInk is able to offer its pharmaceutical customers innovative solutions to fight counterfeiting and illegal diversion of blockbuster pharmaceutical products. Other key applications include nanoscale additive repair, and nanoscale rapid prototyping. Located in the new Illinois Science + Technology Park, north of Chicago, NanoInk currently has over 100 issued or pending patents and patent applications filed worldwide and has licensing agreements with Northwestern University, Stanford University, the University of Illinois at Urbana-Champaign, and the Georgia Institute of Technology.

For more information, please click here

Contacts:
David Gutierrez
Dresner Corporate Services
NanoInk
312-780-7204


Joshua Taustein
Dresner Corporate Services
NanoInk
312-780-7219

Copyright © NanoInk, Inc.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Scientists reveal breakthrough in optical fiber communications December 21st, 2014

Atom-thick CCD could capture images: Rice University scientists develop two-dimensional, light-sensitive material December 20th, 2014

Oregon researchers glimpse pathway of sunlight to electricity: Collaboration with Lund University uses modified UO spectroscopy equipment to study 'maze' of connections in photoactive quantum dots December 19th, 2014

Instant-start computers possible with new breakthrough December 19th, 2014

Nanomedicine

Creation of 'Rocker' protein opens way for new smart molecules in medicine, other fields December 18th, 2014

Iranian Researchers Produce Electrical Pieces Usable in Human Body December 18th, 2014

Unraveling the light of fireflies December 17th, 2014

First Home-Made Edible Herbal Nanodrug Presented to Pharmacies across Iran December 17th, 2014

Announcements

Scientists reveal breakthrough in optical fiber communications December 21st, 2014

Atom-thick CCD could capture images: Rice University scientists develop two-dimensional, light-sensitive material December 20th, 2014

Oregon researchers glimpse pathway of sunlight to electricity: Collaboration with Lund University uses modified UO spectroscopy equipment to study 'maze' of connections in photoactive quantum dots December 19th, 2014

Instant-start computers possible with new breakthrough December 19th, 2014

Appointments/Promotions/New hires/Resignations/Deaths

Aculon Hires New Business Development Director December 19th, 2014

Nanomedicine expert joins Rice faculty: Gang Bao combines genetic, nano and imaging techniques to fight disease December 17th, 2014

Nexeon Attracts ex-Nokia Product Executive to its Board of Directors December 15th, 2014

Arrowhead Appoints Patrick O'Brien as General Counsel December 4th, 2014

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE